ImmunityBio
IBRX
#4344
Rank
ยฃ1.53 B
Marketcap
ยฃ2.10
Share price
-6.36%
Change (1 day)
-36.00%
Change (1 year)

Revenue for ImmunityBio (IBRX)

Revenue in 2024 (TTM): ยฃ5.53 Million

According to ImmunityBio's latest financial reports the company's current revenue (TTM ) is ยฃ5.82 Million. In 2023 the company made a revenue of ยฃ0.48 Million an increase over the revenue in the year 2022 that were of ยฃ0.19 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ImmunityBio from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ5.53 M1032.81%
2023 ยฃ0.48 M146.11%
2022 ยฃ0.19 M-71.33%
2021 ยฃ0.69 M55.89%
2020 ยฃ0.44 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA